Table 2.
Baseline characteristics of study participants.
| Characteristic | N = 5585 |
|---|---|
| Duration of follow-up (years) | 3.75 (0.38, 7.11) |
| Clinic characteristics | |
| Age | 62 (28, 82.3) |
| Female | 3410 (61.06%) |
| sBP (mm Hg) | 133 (105, 171) |
| dBP (mm Hg) | 79 (58, 98) |
| Hypertension | 2381 (42.63%) |
| Diabetes | 3330 (59.62%) |
| eGFR (mL/min/1.73 m2) | 81.89 (23, 117) |
| BMI (kg/m2) | 28.4 (19.8, 41) |
| Urinary-peptide-based classifiers | |
| HF2 | −0.29 (−0.76, 0.21) |
| CAD 160-marker | −0.32 (−0.71, 0.03) |
| CKD273 | −0.50 (−0.84, −0.01) |
| Median (95% IC); n (%) | |
Abbreviations: eGFR, estimated glomerular filtration rate (mL/min per 1.73 m2); BMI, body mass index; sBP, systolic blood pressure; dBP, diastolic blood pressure.